Intraepithelial lymphocyte


Intraepithelial lymphocytes are lymphocytes found in the epithelial layer of mammalian mucosal linings, such as the gastrointestinal tract and reproductive tract. However, unlike other T cells, IELs do not need priming. Upon encountering antigens, they immediately release cytokines and cause killing of infected target cells. In the GI tract, they are components of gut-associated lymphoid tissue.
Based on expression of either an αβ T-cell receptor or a γδ TCR IEL T cells can be divide into two major groups. In mice both groups are retained in almost equal proportions. In humans, the majority of IELs are alpha beta T cells. 15% of IELs are gamma delta T cells and thus represent a minor component of human IELs. However, IELs significantly increase under certain conditions, such as celiac disease.

Phenotype

The majority of IELs are CD3+, and over 75% of these also express CD8. IELs can be divide into two major subsets based on their CD8 coreceptor expression. One subset of IELs typically express activation marker CD8αα and some IELs express CD8αβ+ marker.
In both humans and mice IELs express higher levels of CD103, activation marker CD69, granzyme B and perforin cytolytic granules. CD25 expression is lower in comparison with effector memory T cells.

Development

Induced IELs are generated from naive T cells during an immune response. TCRαβ+ CD8αα cells differentiate in the thymus.
Development and cytolytic activation are independent of live micro-organisms but they become cytolytic in response to the exogenous antigenic substances other than live micro-organisms in the gut. EIL T cells acquired their activated memory phenotype post-thymically, in response to antigens encountered in the periphery.

Function

Their role in immune system is crucial because IELs provide a first line of defense at this extensive barrier with the outside world. All IEL T cells are antigen-experienced T cells, which typically display a cytotoxic functional phenotype. IELs mediate antigen-specific delayed-type hypersensitivity responses, exhibit virus-specific CTL function, to express natural killer -like activity and produce a local graft-versus-host reaction when transferred to semiallogeneic hosts. IELs are also able to produce a variety of cytokines which are characteristically produced by Th1- and Th2-type cells and can also provide help for B cell responses.

Pathology

An elevated IEL population, as determined by biopsy, typically indicates ongoing inflammation within the mucosa. In diseases such as celiac sprue, IEL elevation throughout the small intestine is one of many specific markers. IELs have heightened activated status that can lead to inflammatory disease such as IBD, promote cancer development and progression, or become the malignant cells in enteropathy-associated T-cell lymphoma, a lymphoma that is a complication of celiac sprue.
Alternatively, elevated IEL populations can be a marker for developing neoplasia in the tissue such as found in cervical and prostate cancers, as well as some colorectal cancers, particularly those associated with Lynch syndrome. IELs themselves can, when chronically activated, undergo mutation that can lead to lymphoma.